| P50 | author | Elliott D. Kieff | Q43399614 |
| P2093 | author name string | L Wang | |
| | S R Grossman | |
| P2860 | cites work | HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter | Q22007982 |
| | CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 |
| | The TAF(II)250 subunit of TFIID has histone acetyltransferase activity | Q24310327 |
| | Synergistic activation of transcription by CBP and p53 | Q24311979 |
| | The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE | Q24329182 |
| | A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A | Q24336667 |
| | Factors associated with the mammalian RNA polymerase II holoenzyme | Q24546284 |
| | The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2 | Q24564767 |
| | CREB-binding protein/p300 are transcriptional coactivators of p65 | Q24569596 |
| | A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 |
| | Transcription factor-specific requirements for coactivators and their acetyltransferase functions | Q28260156 |
| | Differential roles of p300 and PCAF acetyltransferases in muscle differentiation | Q28276083 |
| | Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat | Q28282041 |
| | Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor | Q28286827 |
| | p300/MDM2 complexes participate in MDM2-mediated p53 degradation | Q28288274 |
| | Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300 | Q28301874 |
| | p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen | Q28565821 |
| | Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome | Q29618064 |
| | Alteration of nucleosome structure as a mechanism of transcriptional regulation | Q29620047 |
| | The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. | Q33292571 |
| | p53-dependent cell cycle control: response to genotoxic stress | Q33547812 |
| | E2F target genes and cell-cycle checkpoint control | Q33638698 |
| | Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure | Q33643991 |
| | Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. | Q33786088 |
| | E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor | Q33856709 |
| | Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300 | Q33996796 |
| | An activity gel assay detects a single, catalytically active histone acetyltransferase subunit in Tetrahymena macronuclei | Q34120369 |
| | Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation | Q34324039 |
| | E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. | Q34381615 |
| | Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. | Q34625121 |
| | Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo | Q35192911 |
| | Critical residues for histone acetylation by Gcn5, functioning in Ada and SAGA complexes, are also required for transcriptional function in vivo | Q35193069 |
| | The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein | Q35648541 |
| | Retracted: Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors | Q35656534 |
| | Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. | Q35829475 |
| | The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation. | Q35859057 |
| | Association of p300 and CBP with simian virus 40 large T antigen | Q36560644 |
| | The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. | Q36635773 |
| | Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation | Q36689004 |
| | An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator | Q36820857 |
| | A region of herpes simplex virus VP16 can substitute for a transforming domain of Epstein-Barr virus nuclear protein 2 | Q37175014 |
| | The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. | Q39551287 |
| | The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. | Q39595067 |
| | Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation | Q41044061 |
| | Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator | Q41133317 |
| | Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 |
| | Early events in Epstein-Barr virus infection of human B lymphocytes | Q45855126 |
| | Binding of general transcription factor TFIIB to an acidic activating region | Q59058683 |
| | Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID | Q59070657 |
| | Critical structural elements of the VP16 transcriptional activation domain | Q67912152 |
| | Purification and characterization of two porcine liver nuclear histone acetyltransferases | Q68708782 |
| | Binding of NF-KB-like factors to regulatory sequences of the c-myc gene | Q70237251 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 430-435 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter | |
| P478 | volume | 97 | |